In general, three different groups of agents were described in the past: (i) mAbs, either targeting the ligand HGF or the receptor Met, (ii) tyrosine kinase inhibitors, targeting the tyrosine kinase domain of Met (and mostly also the TK domain of other RTKs), (iii) a truncated, soluble Met receptor serving as decoy for HGF (44) and the competitive HGF antagonist NK4 (18)
Peptide-based skin support
Consult your doctor in case
I'm a pro-aesthetic person." She says she's "in the business of selling beauty"
1 3 Related Research Compounds Researchers interested in connective tissue biology and regenerative research may also wish to explore BPC-157, TB-500, Glow and KLOW
In addition to the canonical molecules in the Wnt/-catenin signalling pathway mentioned above, many other molecules also affect the signal transduction of the Wnt/-catenin signalling pathway